Richard A Preston

Professor of Clinical

  • 3376 Citations
1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Richard A Preston is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Kidney Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences
Hypertension Medicine & Life Sciences
Antihypertensive Agents Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Thiazides Medicine & Life Sciences
Prazosin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

1 Citation (Scopus)

Outcomes of minority patients with very severe hypertension (>220/>120 mmHg)

Preston, R. A., Arciniegas, R., DeGraff, S., Materson, B. J., Bernstein, J. & Afshartous, D., Feb 1 2019, In : Journal of Hypertension. 37, 2, p. 415-425 11 p.

Research output: Contribution to journalArticle

Hypertension
Hospitalization
Antihypertensive Agents
Blood Pressure
Emergency Treatment

Pharmacokinetics, safety, and tolerability of intravenous durlobactam and sulbactam in subjects with renal impairment and healthy matched control subjects

O'Donnell, J., Preston, R. A., Mamikonyan, G., Stone, E. & Isaacs, R., Jan 1 2019, In : Antimicrobial agents and chemotherapy. 63, 9, e00794-19.

Research output: Contribution to journalArticle

Open Access
Sulbactam
Pharmacokinetics
Kidney
Safety
Chronic Kidney Failure
3 Citations (Scopus)

Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment

Preston, R. A., Mamikonyan, G., DeGraff, S., Chiou, J., Kemper, C. J., Xu, A., Mastim, M., Yeole, R., Chavan, R., Patel, A., Friedland, H. D. & Bhatia, A., Jan 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 1

Research output: Contribution to journalArticle

Polytetrafluoroethylene
Pharmacokinetics
Kidney
Lactams
Intravenous Infusions

Single-center investigation of the pharmacokinetics of WCK 4282 (cefepime-tazobactam combination) in renal impairment

Preston, R. A., Mamikonyan, G., Mastim, M., Garg, D., Kemper, C. J., Xu, A., Yeole, R., Chavan, R., Friedland, H. D. & Bhatia, A., Jan 1 2019, In : Antimicrobial agents and chemotherapy. 63, 10, e00873-19.

Research output: Contribution to journalArticle

Pharmacokinetics
Kidney
Polytetrafluoroethylene
Chronic Kidney Failure
Healthy Volunteers
7 Citations (Scopus)

Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects

Kosloski, M. P., Zhao, W., Marbury, T. C., Preston, R. A., Collins, M. G., Pugatch, D., Mensa, F., Kort, J. & Liu, W., Mar 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 3, e01990-17.

Research output: Contribution to journalArticle

Hepacivirus
Renal Dialysis
Pharmacokinetics
Kidney
Safety